Statements (37)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:person
|
| gptkbp:boardMemberOf |
gptkb:CytomX_Therapeutics
gptkb:Casma_Therapeutics gptkb:Arvinas gptkb:Akouos gptkb:Semma_Therapeutics gptkb:Relypsa gptkb:Tango_Therapeutics gptkb:Novira_Therapeutics gptkb:Pulmatrix gptkb:Kezar_Life_Sciences gptkb:Ribon_Therapeutics gptkb:Aprea_Therapeutics Cydan Vor Biopharma Ensoma Homology Medicines Chinook Therapeutics Cirius Therapeutics Entrada Therapeutics Ideaya Biosciences Pearl Therapeutics RareCyte Raze Therapeutics |
| gptkbp:education |
gptkb:Harvard_Medical_School
gptkb:Harvard_University gptkb:Princeton_University |
| gptkbp:employer |
gptkb:5AM_Ventures
|
| gptkbp:field |
gptkb:biotechnology
venture capital |
| https://www.w3.org/2000/01/rdf-schema#label |
Kush Parmar
|
| gptkbp:nationality |
gptkb:American
|
| gptkbp:occupation |
gptkb:investor
biotech entrepreneur |
| gptkbp:position |
Managing Partner
|
| gptkbp:bfsParent |
gptkb:Versant_Ventures
|
| gptkbp:bfsLayer |
7
|